Ovid Therapeutics
OVID
OVID
88 hedge funds and large institutions have $146M invested in Ovid Therapeutics in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 26 increasing their positions, 22 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
7% more funds holding
Funds holding: 82 → 88 (+6)
69% less call options, than puts
Call options by funds: $1.25M | Put options by funds: $4.02M
Holders
88
Holding in Top 10
1
Calls
$1.25M
Puts
$4.02M
Top Buyers
| 1 | +$24.4M | |
| 2 | +$9.98M | |
| 3 | +$7.62M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$4.52M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.45M |
Top Sellers
| 1 | -$4.08M | |
| 2 | -$2.89M | |
| 3 | -$2.33M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$2.21M |
| 5 |
Renaissance Technologies
New York
|
-$1.64M |